Literature DB >> 23963019

Deep wound infections after spinal fusion in children with cerebral palsy: a prospective cohort study.

Paul D Sponseller1, Amit Jain, Suken A Shah, Amer Samdani, Burt Yaszay, Peter O Newton, Leslie-Marie Thaxton, Tracey P Bastrom, Michelle C Marks.   

Abstract

STUDY
DESIGN: Prospective cohort.
OBJECTIVE: To (1) calculate the rate of deep wound infection in children with cerebral palsy (CP) after spinal fusion surgery; (2) identify factors (patient, laboratory, and surgical) associated with deep wound infection development; and (3) report causative organisms. SUMMARY OF BACKGROUND DATA: Wound infection after spine fusion for CP is more common than after spine fusion for most other diagnoses.
METHODS: We prospectively gathered data on 204 consecutive pediatric patients with CP who underwent surgery at 7 institutions. Univariate and multivariate regression analysis was performed to analyze patient, laboratory, and surgical characteristics to identify factors that were significantly associated with infection development. Statistical significance was set at a value of P less than 0.05.
RESULTS: Deep wound infection developed in 13 (6.4%) children. The mean time to infection development was 34.2 ± 60.2 days. On univariate analysis, older age, larger curve size, presence of gastrostomy/gastrojejunostomy tube, higher preoperative serum white blood cell count, and longer operative time were significantly associated with deep wound infection. On multivariate analysis, only the presence of a gastrostomy/gastrojejunostomy tube remained significant (1.9-fold risk of deep wound infection compared with patients without tubes). Escherichia coli was the most common organism cultured from the wound sites (5 patients). Other infective agents were: Pseudomonas aeruginosa (2), methicillin-susceptible Staphylococcus aureus (1), Proteus mirabilis (1), and polymicrobial organisms (4).
CONCLUSION: Deep wound infection occurred in 6.4% of children with CP after spinal fusion. The presence of a gastrostomy/gastrojejunostomy tube was a significant predictor of infection. Gram-negative organisms were the most common causative agents. Surgeons should be cognizant of these factors when treating children with CP and may consider Gram-negative antibiotic prophylaxis.

Entities:  

Mesh:

Year:  2013        PMID: 23963019     DOI: 10.1097/BRS.0b013e3182a83e59

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  6 in total

Review 1.  Risk factors for surgical site infection following pediatric spinal deformity surgery: a systematic review and meta-analysis.

Authors:  Fei Meng; Junming Cao; Xianzhong Meng
Journal:  Childs Nerv Syst       Date:  2015-02-24       Impact factor: 1.475

2.  What Is the Impact of Center Variability in a Multicenter International Prospective Observational Study on Developmental Dysplasia of the Hip?

Authors:  Kishore Mulpuri; Emily K Schaeffer; Simon P Kelley; Pablo Castañeda; Nicholas M P Clarke; Jose A Herrera-Soto; Vidyadhar Upasani; Unni G Narayanan; Charles T Price
Journal:  Clin Orthop Relat Res       Date:  2016-05       Impact factor: 4.176

3.  Evaluating Trends and Outcomes of Spinal Deformity Surgery in Cerebral Palsy Patients.

Authors:  Emmanuel N Menga; David N Bernstein; Caroline Thirukumaran; Sekinat K McCormick; Paul T Rubery; Addisu Mesfin
Journal:  Int J Spine Surg       Date:  2020-06-30

Review 4.  Multivariate Analysis and Machine Learning in Cerebral Palsy Research.

Authors:  Jing Zhang
Journal:  Front Neurol       Date:  2017-12-21       Impact factor: 4.003

5.  Rabbit model of Staphylococcus aureus implant-associated spinal infection.

Authors:  Oren Gordon; Robert J Miller; John M Thompson; Alvaro A Ordonez; Mariah H Klunk; Dustin A Dikeman; Daniel P Joyce; Camilo A Ruiz-Bedoya; Lloyd S Miller; Sanjay K Jain
Journal:  Dis Model Mech       Date:  2020-07-28       Impact factor: 5.758

6.  Hospital Burdens of Patients With Cerebral Palsy Undergoing Posterior Spinal Fusion for Scoliosis.

Authors:  Albert T Anastasio; Ndeye F Guisse; Kevin X Farley; John M Rhee
Journal:  Global Spine J       Date:  2020-11-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.